INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 420m ago
HOUSE PTR20m ago
SEC 13F20m ago
ROBINHOOD CHAIN20m ago
Corporate insider
WT

Wettig Thane

Director, CEOCIK 0001815638

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells2 / 0
Max Insider Score29
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
11
WT
Wettig ThaneDirector, CEO
KYNBKYNTRA BIO, INC.
Tax withholding
F$1,787
209 sh
Sep 6, 2026Sep 9, 2026
traded Sep 6, 2026
+3dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    KYNTRA BIO, INC.Director, CEO · Nov 17, 2025
5
WT
Wettig ThaneDirector, CEO
KYNBKYNTRA BIO, INC.
Tax withholding
F
$1,329
198 sh
Jun 6, 2026
Jun 9, 2026
traded Jun 6, 2026
+3d
SEC FORM 4

Evidence

5
WT
Wettig ThaneDirector, CEO
KYNBKYNTRA BIO, INC.
Grant or award
A—
60.0K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC FORM 4

Evidence

5
WT
Wettig ThaneDirector, CEO
FGENKYNTRA BIO, INC.
Tax withholding
F$2,181
259 sh
Dec 6, 2025Dec 9, 2025
traded Dec 6, 2025
+3dSEC FORM 4

Evidence

29
WT
Wettig ThaneDirector, CEO
FGENKYNTRA BIO, INC.
Open-market purchase
BUY$25K
2,700 sh
Nov 17, 2025Nov 17, 2025
traded Nov 17, 2025
+0dSEC FORM 4

Evidence

29
WT
Wettig ThaneDirector, CEO
FGENKYNTRA BIO, INC.
Open-market purchase
BUY$9,180
1,000 sh
Nov 13, 2025Nov 17, 2025
traded Nov 13, 2025
+4dSEC FORM 4

Evidence